General MedicationsINTRAVENOUSStandard
VASOPRESSIN
VASOPRESSIN
Standard Dose
20UNITS/100ML (0.2UNITS/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VASOPRESSIN is listed in Drugs@FDA under application 217987 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient VASOPRESSIN Form and strength SOLUTION;INTRAVENOUS - 20UNITS/100ML (0.2UNITS/ML) Sponsor CIPLA Submission history Latest submission status date: 2023-12-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview VASOPRESSIN is listed in Drugs@FDA under application 217987 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VASOPRESSIN Form and strength SOLUTION;INTRAVENOUS - 20UNITS/100ML (0.2UNITS/ML) Sponsor CIPLA Submission history Latest submission status date: 2023-12-06 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.